MDVL MEDAVAIL HLDGS INC

MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference

MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference

PHOENIX, Aug. 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that Mark Doerr, Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023.

A recording of the event will be available at 7:00am ET on September 11, 2023 on the investor relations section of MedAvail’s website at and will be archived for 90 days.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a pharmacy technology company, providing turnkey, in-clinic pharmacy services through its proprietary robotic dispensing technology, the MedAvail MedCenter®. The MedCenter is currently in use in both the primary care and urgent care settings, as well as Federally Qualified Health Centers (FQHCs).

MedAvail promotes patient drug adherence, resulting in better health outcomes. Learn more at .

Contacts:

Investor Relations

Steven Halper/Caroline Paul

Managing Directors, LifeSci Advisors

SOURCE MedAvail Holdings, Inc.



EN
30/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDAVAIL HLDGS INC

 PRESS RELEASE

MedAvail Announces Agreement with New Orleans-Based St. Thomas Communi...

MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters Expands MedAvail’s presence among Federally Qualified Health Centers (FQHCs) PHOENIX, Nov. 28, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with New Orleans-based St. Thomas Community Health Centers for the deployment of two M4 MedCenter kiosks. St. Thomas operates eight Federally Qualified Health Centers (FQHCs), providing affordable he...

 PRESS RELEASE

MedAvail Receives Nasdaq Notification of Non-Compliance Related to Del...

MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Quarterly Report on Form 10-...

 PRESS RELEASE

MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 M...

MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCenters Initial three deployments to be completed in early 2024 at ASP Cares Pharmacy in Las Vegas Agreement repsents expansion of successful relationship with Dallas-based Oak Lawn Pharmacy PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with Pharmacy Fund 1 for the deployment of ten M4 MedCenter kiosks, which will be serviced by ASP Cares Pharmacy. Pharmacy Fund 1 als...

 PRESS RELEASE

MedAvail to Participate in H.C. Wainwright 25th Annual Global Investme...

MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference PHOENIX, Aug. 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that Mark Doerr, Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023. A recording of the event will be available at 7:00am ET on September 11, 2023 on the investor relations section of MedAvail’s website at and will be archived for 90 days. About MedAvail MedAvail Holding...

 PRESS RELEASE

MedAvail Reports Second Quarter 2023 Financial Results

MedAvail Reports Second Quarter 2023 Financial Results PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023. “During the second quarter, we were able to sustain the positive momentum that we have experienced since we began focusing on the immense market opportunity for our pharmacy technology in January of this year,” said Mark Doerr, Chief Executive Officer of MedAvail. “Of note, we placed an additional two revenue generating M...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch